These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro. Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712 [TBL] [Abstract][Full Text] [Related]
6. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states. Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130 [TBL] [Abstract][Full Text] [Related]
7. Treatment with glucokinase activator, YH-GKA, increases cell proliferation and decreases glucotoxic apoptosis in INS-1 cells. Oh YS; Lee YJ; Park K; Choi HH; Yoo S; Jun HS Eur J Pharm Sci; 2014 Jan; 51():137-45. PubMed ID: 24056026 [TBL] [Abstract][Full Text] [Related]
8. Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic hyperglycemia. Otaegui PJ; Ontiveros M; Ferre T; Riu E; Jiménez R; Bosch F Hum Gene Ther; 2002 Dec; 13(18):2125-33. PubMed ID: 12542844 [TBL] [Abstract][Full Text] [Related]
9. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941 [TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt/β-catenin signaling restores insulin sensitivity in insulin resistant neurons through transcriptional regulation of IRS-1. Tian S; Tan S; Jia W; Zhao J; Sun X J Neurochem; 2021 May; 157(3):467-478. PubMed ID: 33336396 [TBL] [Abstract][Full Text] [Related]
11. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats. Frese T; Bazwinsky I; Mühlbauer E; Peschke E Horm Metab Res; 2007 Aug; 39(8):567-74. PubMed ID: 17712721 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of protein tyrosine phosphatase 1B impairs glucose-stimulated insulin secretion in INS-1 cells. Lu B; Gu P; Xu Y; Ye X; Wang Y; DU H; Shao J Minerva Endocrinol; 2016 Mar; 41(1):1-9. PubMed ID: 26099503 [TBL] [Abstract][Full Text] [Related]
13. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643 [TBL] [Abstract][Full Text] [Related]
14. Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulin signaling. Song Z; Wang H; Zhu L; Han M; Gao Y; Du Y; Wen Y Food Funct; 2015 Feb; 6(2):461-9. PubMed ID: 25474544 [TBL] [Abstract][Full Text] [Related]
15. Octanoic acid potentiates glucose-stimulated insulin secretion and expression of glucokinase through the olfactory receptor in pancreatic β-cells. Leem J; Shim HM; Cho H; Park JH Biochem Biophys Res Commun; 2018 Sep; 503(1):278-284. PubMed ID: 29885841 [TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase, muscle isoform 2 promotes proliferation and insulin secretion of pancreatic β-cells via activating Wnt/CTNNB1 signaling. Wang S; Yang Z; Gao Y; Li Q; Su Y; Wang Y; Zhang Y; Man H; Liu H Int J Clin Exp Pathol; 2015; 8(11):14441-8. PubMed ID: 26823761 [TBL] [Abstract][Full Text] [Related]